LP
EWTX icon

LMR Partners’s Edgewise Therapeutics EWTX Stock Holding History

LMR Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$630K Hold
20,000
– – ﹤0.01% 1060
2025
Q4 		$496K Buy
+20,000
New +$401K ﹤0.01% 1126

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

LMR Partners's EWTX Position: Q1 2026 in Review

LMR Partners held its Edgewise Therapeutics (EWTX) position steady in Q1 2026 at 20,000 shares worth $630K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

LMR Partners first reported a position in EWTX in Q4 2025 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • LMR Partners held 20,000 shares of Edgewise Therapeutics worth $630K as of Q1 2026.
  • LMR Partners left its Edgewise Therapeutics share count unchanged in Q1 2026.
  • Edgewise Therapeutics made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1060 holding.
  • LMR Partners first reported a position in Edgewise Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.